Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 46 records per page: next > | last >>
pages: 1 2 3 4 5 ... 43 44 45 46 presentations: 1 to 25 of 1142
Key questions for ctDNA analysis
Paul T Spellman
Oregon Health Science Univ., Portland, OR, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Title to be announced
Jamie Platt
Inivata, Research Triangle Park, NC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
The dual roles of analytical and clinical data in ctDNA test validation
Justin Odegaard
Guardant Health Inc., Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Analytical validation of liquid biopsy assays: current challenges and opportunities
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Cancer therapeutics: A view from the microbiota
Christian Jobin
Univ. of Florida, Gainesville, FL, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Dynamic monitoring of the dysbiotic microbiome
Jonathan Braun
Mt. Sinai Medical Center, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Identification and targeting microbial vulnerabilities
Ami S Bhatt
Stanford Medical School, Stanford, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Encapsulated fecal transplant: It's not just for Clostridium difficile any more!
Elizabeth L Hohmann
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Introduction
Massimo Loda
Cornell Univ., Ithaca, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Pathology for cancer researchers: An overview
Jiaoti Huang
Duke Univ. School of Medicine, Durham, NC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Antibody validation of immunohistochemistry (IHC) and in situ hybridization assays in tissue: Pitfalls, tips, and techniques
Angelo M De Marzo
John Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Molecular pathology and diagnostics
Andrea L Richardson
Johns Hopkins Univ. School of Medicine, Washington, DC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Computational pathology, imaging, and artificial intelligence
Andrew H Beck
PathAI, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
From discovery to clinics: Design considerations in biomarker studies
Yingye Zheng
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Needle in a haystack: Biomarker discovery in high-dimensional data
Shilin Zhao
Vanderbilt University Medical Center, Nashville, TN, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Precision oncology: Integrating biomarkers in phase III clinical trial designs
Antje Hoering
Cancer Research and Biostatistics, Seattle, WA, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Population risk stratification: Integrating biomarkers in cancer risk assessment
Ruth Pfeiffer
NCI-DCEG, Bethesda, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Intended clinical application drives your study design: Principles and operational considerations
Ziding Feng
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Evaluating biomarkers for prognostic enrichment of clinical trials
Kathleen Kerr
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Deriving early detection biomarker performance goals by setting a minimum benefit-to-harm ratio
Steven J Skates
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Machine learning in imaging: Seeing the invisible
Christos Davatzikos
Center for Biomedical Image Computing and Analytics, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Machine learning in imaging: Seeing the invisible
Saima Rathore
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Deep learning: Promises and challenges
Jayashree Kalpathy-Cramer
Harvard Medical School/MGH, Charlestown, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Deep learning for reading mammograms: state-of-the-art and clinical implementation
Regina Barzilay
MIT, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
AI tools for computational pathology
Lee Cooper
Emory University, Atlanta, GA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
<< first | < prev page: of 46 records per page: next > | last >>
pages: 1 2 3 4 5 ... 43 44 45 46 presentations: 1 to 25 of 1142